Showing results (11-20 of 284) with videos related to
Sort By:
Pageof 29
Expert Review of Cardiovascular Therapy|April 5, 2014
Fibroblast growth factor 21: a promising therapeutic target in obesity-related diseasesBernard M Y Cheung, H B DengEuropean Journal of Cancer (Oxford, England : 1990)|January 16, 2008
Loading doses for costly cancer biologicals: sound pharmacology or unnecessary extravagance?Richard J Epstein, Bernard M Y CheungCardiovascular & Hematological Disorders Drug Targets|June 23, 2007
The metabolic syndrome and vascular disease in AsiaBernard M Y Cheung, G Neil ThomasBritish Journal of Clinical Pharmacology|October 26, 2011
The pharmacogenetics of the response to warfarin in ChineseMay P S Lam, Bernard M Y CheungExpert Review of Clinical Pharmacology|March 7, 2012
The use of STOPP/START criteria as a screening tool for assessing the appropriateness of medications in the elderly populationMay P S Lam, Bernard M Y CheungCurrent Hypertension Reports|March 25, 2017
The Potential Role of Fibroblast Growth Factor 21 in Lipid Metabolism and HypertensionZhe Huang, Aimin Xu, Bernard M Y CheungClinical Therapeutics|February 3, 2019
Clinical Therapeutics in Hong KongBernard M Y Cheung, Henry K C YauTherapeutic Advances in Drug Safety|August 2, 2014
Safety of statins: an updateMiao Hu, Bernard M Y Cheung, Brian TomlinsonCardiovascular Toxicology|January 28, 2025
Associations Between Lead and Cadmium Exposure and Subclinical Cardiovascular Disease in U.S. AdultsLin Liu, Aimin Xu, Bernard M Y CheungHong Kong Medical Journal = Xianggang Yi Xue Za Zhi|November 20, 2018
Post-fracture care gap: a retrospective population-based analysis of Hong Kong from 2009 to 2012M Y Cheung, A Wh Ho, S H WongPageof 29